NAUTILUS BIOTECHNOLOGY INC (NAUT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:NAUT • US63909J1088

2.03 USD
+0.01 (+0.5%)
Last: Feb 6, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NAUT. NAUT was compared to 58 industry peers in the Life Sciences Tools & Services industry. No worries on liquidiy or solvency for NAUT as it has an excellent financial health rating, but there are worries on the profitability. NAUT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • NAUT had negative earnings in the past year.
  • NAUT had a negative operating cash flow in the past year.
  • In the past 5 years NAUT always reported negative net income.
  • NAUT had a negative operating cash flow in each of the past 5 years.
NAUT Yearly Net Income VS EBIT VS OCF VS FCFNAUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • NAUT has a worse Return On Assets (-31.26%) than 77.19% of its industry peers.
  • NAUT has a Return On Equity of -37.14%. This is in the lower half of the industry: NAUT underperforms 63.16% of its industry peers.
Industry RankSector Rank
ROA -31.26%
ROE -37.14%
ROIC N/A
ROA(3y)-22.18%
ROA(5y)-19.51%
ROE(3y)-25.43%
ROE(5y)-22%
ROIC(3y)N/A
ROIC(5y)N/A
NAUT Yearly ROA, ROE, ROICNAUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NAUT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NAUT Yearly Profit, Operating, Gross MarginsNAUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • The number of shares outstanding for NAUT has been increased compared to 1 year ago.
  • Compared to 5 years ago, NAUT has more shares outstanding
  • NAUT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NAUT Yearly Shares OutstandingNAUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
NAUT Yearly Total Debt VS Total AssetsNAUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • NAUT has an Altman-Z score of 2.20. This is not the best score and indicates that NAUT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.20, NAUT perfoms like the industry average, outperforming 59.65% of the companies in the same industry.
  • NAUT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.2
ROIC/WACCN/A
WACCN/A
NAUT Yearly LT Debt VS Equity VS FCFNAUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 14.95 indicates that NAUT has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 14.95, NAUT belongs to the top of the industry, outperforming 96.49% of the companies in the same industry.
  • A Quick Ratio of 14.95 indicates that NAUT has no problem at all paying its short term obligations.
  • NAUT has a better Quick ratio (14.95) than 96.49% of its industry peers.
Industry RankSector Rank
Current Ratio 14.95
Quick Ratio 14.95
NAUT Yearly Current Assets VS Current LiabilitesNAUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 10.71% over the past year.
EPS 1Y (TTM)10.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.38%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 4.58% on average over the next years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y8.93%
EPS Next 2Y-5.41%
EPS Next 3Y4.58%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAUT Yearly Revenue VS EstimatesNAUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
NAUT Yearly EPS VS EstimatesNAUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NAUT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NAUT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAUT Price Earnings VS Forward Price EarningsNAUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAUT Per share dataNAUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.41%
EPS Next 3Y4.58%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • NAUT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NAUTILUS BIOTECHNOLOGY INC

NASDAQ:NAUT (2/6/2026, 8:00:01 PM)

2.03

+0.01 (+0.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-28
Earnings (Next)02-26
Inst Owners33.71%
Inst Owner Change1.26%
Ins Owners32.36%
Ins Owner Change0.01%
Market Cap256.41M
Revenue(TTM)N/A
Net Income(TTM)-62.81M
Analysts85
Price Target2.55 (25.62%)
Short Float %0.52%
Short Ratio1.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.1%
Min EPS beat(2)24.1%
Max EPS beat(2)28.1%
EPS beat(4)4
Avg EPS beat(4)20.14%
Min EPS beat(4)13.06%
Max EPS beat(4)28.1%
EPS beat(8)8
Avg EPS beat(8)16.81%
EPS beat(12)12
Avg EPS beat(12)19.37%
EPS beat(16)16
Avg EPS beat(16)19.47%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.52
P/tB 1.52
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.42
OCFYN/A
SpS0
BVpS1.34
TBVpS1.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.26%
ROE -37.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.18%
ROA(5y)-19.51%
ROE(3y)-25.43%
ROE(5y)-22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 72.3%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.95
Quick Ratio 14.95
Altman-Z 2.2
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)143.23%
Cap/Depr(5y)156.36%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.38%
EPS Next Y8.93%
EPS Next 2Y-5.41%
EPS Next 3Y4.58%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year22.66%
EBIT Next 3Y-1.43%
EBIT Next 5Y0.35%
FCF growth 1Y46.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.21%
OCF growth 3YN/A
OCF growth 5YN/A

NAUTILUS BIOTECHNOLOGY INC / NAUT FAQ

What is the fundamental rating for NAUT stock?

ChartMill assigns a fundamental rating of 3 / 10 to NAUT.


What is the valuation status for NAUT stock?

ChartMill assigns a valuation rating of 0 / 10 to NAUTILUS BIOTECHNOLOGY INC (NAUT). This can be considered as Overvalued.


How profitable is NAUTILUS BIOTECHNOLOGY INC (NAUT) stock?

NAUTILUS BIOTECHNOLOGY INC (NAUT) has a profitability rating of 0 / 10.